Join a
MASH Cirrhosis Clinical Study
in San Antonio
Get a Free Liver Exam
Earn up to $5,000 for Time & Travel
Explore potential treatment options for Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Cirrhosis. Medical experts are researching the investigational drug, pegozafermin, to see how effective it is at treating advanced liver scarring in people with MASH-related cirrhosis.
You may qualify to participate in the Cirrhosis study if you are 18-80 years old and have been diagnosed with MASH-related cirrhosis.
See if you may be eligible to join the Cirrhosis clinical trial at Quality Research
Call 210-824-5678 or complete the form.